From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Women's Health>
  4. Summary and Comment

Flash: Plant Estrogens Don't Help

Postmenopausal women with vasomotor symptoms derived no more benefit from phytoestrogens than from placebo.

Phytoestrogens, commonly found in edible plants such as soybeans and red clover, bind weakly to the estrogen receptor and are marketed widely as a nonhormonal treatment alternative for hot flashes. But, do they work? In this double-blind trial, 62 postmenopausal symptomatic women were randomized to receive phytoestrogens (isoflavonoids, 114 mg/day) or placebo for 3 months; after a 2-month washout period, the women crossed over to the other arm for 3 months. All women previously had been treated for breast cancer and complained of incapacitating hot flashes, night sweats, and sleeplessness.

Among the 56 women who completed the study, 25 (44.5%) preferred the phytoestrogens, 15 (26.8%) preferred the placebo (nonsignificant difference), and 16 (28.6%) had no preference. Mean hot-flash score (Kupperman index), working-capacity index, and mood index did not differ significantly after phytoestrogen treatment compared with placebo, nor did liver-enzyme levels, hormone parameters, BMI, or blood pressure. The only significant difference was an increase in serum phytoestrogen concentration after phytoestrogen treatment.

Comment: The results from this well-designed, crossover trial prove that phytoestrogens are ineffective in treating menopausal symptoms. The impressive placebo effect underscores the importance of having data from trials with placebo arms before making clinical recommendations for the treatment of vasomotor symptoms.

— Sandra Ann Carson, MD

Published in Journal Watch Women's Health August 6, 2003

Citation(s):

Nikander E et al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol 2003 Jun; 101:1213-20.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2003. Massachusetts Medical Society. All rights reserved.